Featured
TGA dishes five-figure prescription drug fine
The Head of the TGA has threatened continued "strong compliance and enforcement action" after the Regulator issued its second significant fine in just over a month
Featured
Black market booms for future blockbuster
This drug is still months off being filed for approval but there's already a booming black market with the Big Pharma that developed it taking a tough legal stand
Jobs
Industry & Companies
'Rare' uptick in pharma's corporate reputation
Rare disease patient groups have picked their favourite pharma with industry's overall reputation rising to levels not seen for five years - but companies still have plenty to improve on
Latest
Who's got a new job at an old company?
Job movements continue across industry and it's not always for somewhere new - with two industry executives returning to companies where they've worked before
Industry & Companies
Aussie company on track to bank its first billion
Australia's largest radiopharma is determined that it's just getting started, increasing R&D spend twice as fast as revenue
Leadership & People
Digital platform expands Senior Leadership team
Two new senior roles have been created, filled by an internal promotion and external hire, as the company expands its platform across Asia Pacific
Leadership & People
Company bumps up Aussie Leadership Team
The appointment of two experienced industry executives to major roles underlines this pharma's "commitment to investing in world-class talent and building capability to deliver on ambitious plans for the future," the Managing Director said.
Industry & Companies
What headwinds? Companies notch double-digit growth
Despite concerns over strong challenges facing the pharmaceutical sector, the industry saw strong revenue growth in the second quarter of this year. Find out which companies are flying
Regulation & Legal
First win for J&J over alleged ineffective medicine
Members of a class action alleging the pharma knowingly sold ineffective medicine must register or risk missing out on a possible settlement
Featured
Whose share price almost tripled overnight?
New trial results could redefine how cancer patients are treated with two companies experiencing a massive boost in share price and market cap, with one pharma seeing its stock almost triple in value
Latest
How many of the best US drugs have reached Australia?
Just three of the 21 drugs named finalists for the prestigious 2026 Prix Galien USA Awards in the best pharmaceutical product category are subsidised in Australia
Industry & Companies
Aussie GMs unpack pricing pain points
Even with solid Phase 3 results showing a drug has a large benefit to patients, pharmas may hold off launching a drug in Australia over pricing
Regulatory & Reimbursement
17 drugs vie for September PBS listing
A bumper start to Spring is on the cards with a long list of submissions recommended by the PBAC currently sitting in the last stage before listing occurs
Industry & Companies
Pharma a bright spot in CSL's "reset" year
In a year of declining revenue and a multi-billion dollar reported loss, the local giant had strong growth in many of its pharma products
- Regulatory & Reimbursement Blockbuster earnings nosedive by 80%
- Other News The hidden $1.2B cost of two diseases
- Industry & Companies NEXT Summit in full swing in Sydney
- Regulatory & Reimbursement Swedish pharma launches first drug
- Jobs & Workplace Big Pharma on Aussie hiring spree
- Industry & Companies Novo teams up with Rural Doctors Foundation
- Other News Pharma boosts pipeline to 39 assets
- Regulatory & Reimbursement Fast response after PBAC Special Meeting
- Regulatory & Reimbursement 14 drugs land on TGA's review desk
- Industry & Companies Who's the Most Productive pharma?
